XML 40 R27.htm IDEA: XBRL DOCUMENT v3.21.2
SCHEDULE OF FAIR VALUE ASSUMPTIONS FOR OPTIONS GRANTED (Details)
9 Months Ended
Sep. 30, 2021
$ / shares
Equity [Abstract]  
Price at valuation $ 1.04
Exercise price $ 1.04
Risk free interest 0.49%
Expected term (in years) 5 years
Volatility 81.50%